Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation

被引：0
|
作者：
Gue, Y. X. [1 ]
Bloomfield, D. [2 ]
Freedholm, D. [2 ]
Lip, G. [1 ]
机构：
[1] Univ Liverpool, Sch Med, Liverpool, England
[2] Anthos Therapeut, Cambridge, MA USA
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] "Unreal world" or "real world" data in oral anticoagulant treatment of atrial fibrillation
    Freedman, Ben
    Lip, Gregory Y. H.
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) : 587 - 589
  • [42] Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations?
    Boriani, Giuseppe
    Tartaglia, Enrico
    Imberti, Jacopo F.
    KARDIOLOGIA POLSKA, 2024, 82 (01) : 7 - 9
  • [43] Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data
    Moret, Carla
    Acosta-Isaac, Rene
    Mojal, Sergi
    Corrochano, Mariana
    Jimenez, Blanca
    Plaza, Melania
    Souto, Juan Carlos
    PLOS ONE, 2023, 18 (02):
  • [44] Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation
    Manzoor, Beenish S.
    Lee, Todd A.
    Sharp, Lisa K.
    Walton, Surrey M.
    Galanter, William L.
    Nutescu, Edith A.
    PHARMACOTHERAPY, 2017, 37 (10): : 1221 - 1230
  • [45] Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study
    Rachel Eikelboom
    Richard P. Whitlock
    Serena Sibilio
    Francis Nguyen
    Richard Perez
    Jeffrey I. Weitz
    Emilie Belley-Cote
    Cardiovascular Drugs and Therapy, 2024, 38 : 109 - 117
  • [46] REVERSAL AGENTS IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS HOSPITALIZED FOR BLEEDING: A REAL-WORLD ANALYSIS
    Robinson, Scott
    Bowdy, Bruce D.
    Jing, Yonghua
    Schaiff, Robyn
    Lee, Veronica
    McMahon, Ellen
    Johnson, Bernadette H.
    Wiederkehr, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A419 - A419
  • [47] Real-World Risk of Thromboembolism or Bleeding with Warfarin or Dabigatran Therapy in Patients with Atrial Fibrillation
    Charland, Scott I.
    Malone, Daniel C.
    Agatep, Barnabie C.
    Herrera, Vivian
    Hawk, Gosia S.
    Schrader, Bruce J.
    Stanek, Eric J.
    CIRCULATION, 2012, 126 (21)
  • [48] Direct Oral Anticoagulation Versus Warfarin in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves: a Retrospective, Real-World Cohort Study
    Eikelboom, Rachel
    Whitlock, Richard P.
    Sibilio, Serena
    Nguyen, Francis
    Perez, Richard
    Weitz, Jeffrey, I
    Belley-Cote, Emilie
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (01) : 109 - 117
  • [49] Real-world Difficulties in Conducting a Clinical Trial on Life-Style Modifications in Patients With Atrial Fibrillation
    Mohanty, Sanghamitra
    Trivedi, Chintan
    Gianni, Carola
    Al-Ahmad, Amin
    Burkhardt, John D.
    Horton, Rodney
    Sanchez, Javier
    Hranitzky, Patrick
    Gallinghouse, G. J.
    Della Rocca, Domenico G.
    Di Biase, Luigi
    Natale, Andrea
    CIRCULATION, 2017, 136
  • [50] Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation
    Steinberg, Benjamin A.
    Ballew, Nicholas G.
    Greiner, Melissa A.
    Lippmann, Steven J.
    Curtis, Lesley H.
    O'Brien, Emily C.
    Patel, Manesh R.
    Piccini, Jonathan P.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2019, 5 (12) : 1384 - 1392
12345